One in two Americans will develop dementia in lifetime, study suggests
Nearly one in two Americans will develop dementia in their lifetimes, according to New York University researchers who say ...
Hosted on MSN20m
ProMIS Neurosciences launch Phase Ia AβO Alzheimer’s trial
The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.
How to help prevent winter wandering for those with Alzheimer's disease
If you have a loved one living with Alzheimer's disease, winter can be a difficult season to navigate, between the icy sidewalks and chance of them wandering by ...
Healio23m
Early blarcamesine use slows AD progression over 3 years
Topline results from a phase 2b/3 clinical trial of blarcamesine for individuals with early-stage Alzheimer’s disease showed ...
Dementia risk may be twice as high as Americans live longer, study finds
The risk of developing dementia may be much higher than previously thought, a study published Monday in the journal Nature Medicine has found.